CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cryofocus Medtech Shanghai Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cryofocus Medtech Shanghai Co Ltd
Lane 3399
Kangxin Highway, Pudong New Area
Phone: +86 2120977850p:+86 2120977850 SHANGHAI, SHA  201318  China Ticker: 69226922
Business Summary
Cryofocus Medtech Shanghai Co Ltd is a China-based company mainly engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. The Company is also engaged in the manufacture and sale of minimally-invasive surgical consumables. The Company focuses on two therapeutic areas: vascular interventional therapy for the treatment of atrial fibrillation, hypertension and other cardiovascular diseases and natural orifice transluminal endoscopic surgery, for the treatment of urinary, respiratory, and digestive diseases (such as bladder cancer, chronic obstructive pulmonary disease, asthma, airway stenosis, gastric cancer, and esophageal cancer). The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023-----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
3841 Surgical and medical instruments and apparatus
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board KejianLi 53 12/28/2021 3/15/2013
Chief Financial Officer, Executive Director, Joint Company Secretary, Board Secretary WeiLiu 32 6/16/2023 10/12/2020
General Manager, Executive Director JunZhu 48 12/28/2021 10/1/2020
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 370 (As of 6/30/2024)
Outstanding Shares: 239,110,000 (As of 6/30/2024)
Stock Exchange: HKG


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025